Skip to main content
. 2023 Oct 11;24(20):15097. doi: 10.3390/ijms242015097

Figure 1.

Figure 1

(A) LAP-TGF-β was significantly increased in DD-FBs in contrast to carpal tunnel syndrome (CTS)-FBs without (w/o) or with TGF-β1 (TGF-β). The analysis was performed with a fluorescence activated cell scanner. And the treatment with TGF-β1 significantly accelerated LAP-TGF-β expression in DD- and CTS-FBs (n = 11–14). (B) LAP-TGF-β was significantly increased in DD-FBs in contrast to CTS-FBs; herein a Western blot analysis was performed. * and # p ≤ 0.05; # CTS- and DD-FBs were compared treated without (w/o) or with TGF-β1. Bars represent the mean ± SD of individual experiments indicated (n = 11–15).